​

TG Therapeutics Ownership | Who Owns TG Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

TG Therapeutics Ownership Summary

TG Therapeutics is owned by 69.49% institutional investors, 9.50% insiders, and 21.01% retail investors. Vanguard group is the largest institutional shareholder, holding 9.36% of TGTX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.53% of its assets in TG Therapeutics shares.

TGTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTG Therapeutics69.49%9.50%21.01%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group13.69M9.36%$243.58M
Blackrock11.39M7.79%$202.60M
State street6.70M4.58%$119.12M
Soleus capital management3.65M2.49%$64.85M
Pictet asset management sa3.24M2.22%$57.70M
Geode capital management3.21M2.19%$57.05M
Deep track capital, lp2.87M1.96%$51.06M
Opaleye management2.28M1.56%$40.56M
Goldman sachs group2.08M1.43%$37.09M
Bank of america corp /de/2.08M1.42%$37.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management2.28M9.27%$40.56M
Soleus capital management3.65M5.72%$64.85M
Exome asset management251.60K3.98%$4.48M
M28 capital management lp161.60K3.73%$2.87M
Castellan group283.68K3.70%$8.54M
Ghost tree capital500.00K2.79%$8.89M
683 capital management1.40M1.88%$24.91M
Sofinnova investments1.86M1.72%$33.11M
Deep track capital, lp2.87M1.52%$51.06M
Spotlight asset group82.10K1.02%$1.46M

Top Buyers

HolderShares% AssetsChange
Deep track capital, lp2.87M1.52%2.87M
Two sigma investments, lp1.36M0.06%1.10M
Goldman sachs group2.08M0.01%798.28K
Norges bank597.30K0.00%597.30K
Blackrock11.39M0.00%544.84K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp65.07K0.00%-3.09M
Marshall wace, llp---2.05M
State street6.70M0.01%-1.10M
Vestal point capital, lp---1.05M
Balyasny asset management---802.00K

New Positions

HolderShares% AssetsChangeValue
Deep track capital, lp2.87M1.52%2.87M$51.06M
Norges bank597.30K0.00%597.30K$10.63M
Castellan group283.68K3.70%283.68K$8.54M
Two sigma advisers, lp166.10K0.01%166.10K$2.95M
Van eck associates140.15K0.01%140.15K$4.22M

Sold Out

HolderChange
Quest partners-1.00
Mendota financial group-4.00
Financial gravity asset management-5.00
Ica group wealth management-25.00
Federation des caisses desjardins du quebec-40.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202432518.18%100,828,8388.07%691.67%18730.77%7410.45%
Jun 30, 20242734.20%93,287,9134.27%631.63%14212.70%67-10.67%
Mar 31, 20242621.16%89,470,240-0.55%621.58%1269.57%752.74%
Dec 31, 20232590.39%89,964,1210.71%621.58%115-16.67%7325.86%
Sep 30, 2023258-5.84%89,331,9491.53%631.61%138-0.72%58-19.44%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF8.62M5.53%3.79K
Vanguard Total Stock Mkt Idx Inv4.37M2.81%44.83K
SPDR® S&P Biotech ETF3.78M2.43%-44.12K
iShares Russell 2000 ETF3.74M2.41%-14.38K
Vanguard Small Cap Index3.57M2.29%53.60K
Vanguard Small Cap Growth Index Inv2.02M1.30%90.71K
Vanguard Institutional Extnd Mkt Idx Tr2.01M1.29%13.63K
Pictet Biotech1.79M1.16%1.79M
Fidelity Small Cap Index1.43M0.92%5.42K
Pictet-Global Megatrend Sel I USD1.37M0.88%48.77K

Recent Insider Transactions

DateNameRoleActivityValue
Jan 06, 2025Power Sean A CFOSell$285.94K
Jan 03, 2025Power Sean A CFOSell$343.44K
Nov 11, 2024Lonial Sagar-Sell$152.20K
Nov 11, 2024Charney Laurence N-Sell$754.88K
Nov 05, 2024Echelard Yann-Sell$489.60K

Insider Transactions Trends

DateBuySell
2024 Q4-3
2024 Q2-2
2024 Q1-4
2023 Q31-
2023 Q2-2

TGTX Ownership FAQ

Who Owns TG Therapeutics?

TG Therapeutics shareholders are primarily institutional investors at 69.49%, followed by 9.50% insiders and 21.01% retail investors. The average institutional ownership in TG Therapeutics's industry, Biotech Stocks , is 109.70%, which TG Therapeutics falls below.

Who owns the most shares of TG Therapeutics?

TG Therapeutics’s largest shareholders are Vanguard group (13.69M shares, 9.36%), Blackrock (11.39M shares, 7.79%), and State street (6.7M shares, 4.58%). Together, they hold 21.73% of TG Therapeutics’s total shares outstanding.

Does Blackrock own TG Therapeutics?

Yes, BlackRock owns 7.79% of TG Therapeutics, totaling 11.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 202.6M$. In the last quarter, BlackRock increased its holdings by 544.84K shares, a 5.02% change.

Who is TG Therapeutics’s biggest shareholder by percentage of total assets invested?

Opaleye management is TG Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.27% of its assets in 2.28M TG Therapeutics shares, valued at 40.56M$.

Who is the top mutual fund holder of TG Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of TG Therapeutics shares, with 5.53% of its total shares outstanding invested in 8.62M TG Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools